Advancing Multiple Sclerosis Treatment and Outcomes: Access, Adherence and Site of Care Obstacles
Earn CME: https://www.naccme.com/program/19-hqc-101-2
This webcast features presentations that discuss overcoming obstacles to patient care, with a focus on access, adherence, and site of care barriers.
© 2019 NACCME, an HMP Company
Видео Advancing Multiple Sclerosis Treatment and Outcomes: Access, Adherence and Site of Care Obstacles канала ImedexCME
This webcast features presentations that discuss overcoming obstacles to patient care, with a focus on access, adherence, and site of care barriers.
© 2019 NACCME, an HMP Company
Видео Advancing Multiple Sclerosis Treatment and Outcomes: Access, Adherence and Site of Care Obstacles канала ImedexCME
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Multiple Sclerosis - The State of the ArtAdvancing Multiple Sclerosis Treatment and Outcomes: Access, Adherence, and other ObstaclesJohn Schafer, MD: New Treatment Options for Multiple SclerosisClinical Approaches to the Effective Treatment of C. diff as an Infectious DiseaseWalking and MS - Ben Thrower, M.D. - MSFocus at Sea 2019Diagnosis and Management of HeadacheManagement and Treatment of COPDMS and Fatigue: Tired of Being Tired - Ben Thrower, M.D. - November 2015Joel Fuhrman, M.D. on Treating Disease with a Nutritarian DietRadical Russian stem-cell treatment could slow down multiple sclerosis | 60 Minutes AustraliaImpacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary ManagementMultiple sclerosis - causes, symptoms, diagnosis, treatment, pathologyResearch Update: The Role of Diet on Cognition in Multiple Sclerosis with Dr Heather FrancisMultiple Sclerosis and Autoimmune Diseases: The Impact of Diet - John McDougall, MDNeuroscience Updates Online - Fall 2020 - Multiple Sclerosis: Pathogenesis, Diagnosis, & TreatmentRemyelination for Multiple Sclerosis, Luke Lairson, PhDJAK Therapies: Mechanism of Action, Pharmacotherapeutic Profiles, and PositioningMultiple Sclerosis: Signs, Symptoms and TreatmentsMS in Patients Over 60: Different disease? Different treatment?Primary Progressive MS - Ben Thrower, M.D. - May 2017